Cargando…
Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective
Since the early observations that nitric oxide ((•)NO) at high concentrations is cytotoxic to cancer cells and that it may play an important role in the treatment of human cancers, a significant number of compounds (NO-donors) have been prepared to deliver (•)NO to tumors. (•)NO also sensitizes vari...
Autor principal: | Sinha, Birandra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487592/ https://www.ncbi.nlm.nih.gov/pubmed/37686417 http://dx.doi.org/10.3390/ijms241713611 |
Ejemplares similares
-
NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells
por: Sinha, Birandra K., et al.
Publicado: (2021) -
Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells
por: Sinha, Birandra K., et al.
Publicado: (2017) -
Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy
por: Sinha, Birandra K., et al.
Publicado: (2023) -
The inducible nitric oxide synthase-inhibitor 1400W as a potential treatment for retinal diseases
por: Schnichels, Sven, et al.
Publicado: (2020) -
Self-experimentation in the COVID Era: Is it morally justifiable? – A perspective
por: Sinha, Ankit, et al.
Publicado: (2022)